INDmoney
CORT
Corcept Therapeutics Inc Earnings
$35.73
Earnings Summary
Revenue | $202.13Mn |
Net Profits | $24.29Mn |
Net Profit Margins | 12.02% |
Corcept Therapeutics Inc’s revenue jumped 11.12% since last year same period to $202.13Mn in the Q4 2025. On a quarterly growth basis, Corcept Therapeutics Inc has generated -2.66% fall in its revenue since last 3-months.
Corcept Therapeutics Inc’s net profit fell -20.08% since last year same period to $24.29Mn in the Q4 2025. On a quarterly growth basis, Corcept Therapeutics Inc has generated 25.46% jump in its net profits since last 3-months.
Corcept Therapeutics Inc’s net profit margin fell -28.08% since last year same period to 12.02% in the Q4 2025. On a quarterly growth basis, Corcept Therapeutics Inc has generated 28.88% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | -0.15 |
EPS Estimate Current Year | -0.15 |
Corcept Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at -0.15 - a -159.57% fall from last quarter’s estimates.
Corcept Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at -0.15.
Key Ratios
Earning Per Share (EPS) | 0 |
Corcept Therapeutics Inc’s earning per share (EPS) fell -100% since last year same period to 0 in the Q1 2026. This indicates that the Corcept Therapeutics Inc has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2026-05-06 | -0.15 | 0 | 100% |
